Antibodies

Aims & Scope

Antibodies (ISSN 2073-4468), an international, peer-reviewed open access journal which provides an advanced forum for studies related to antibodies and antigens.

It publishes reviews, research articles, communications and short notes.

Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.

There is no restriction on the length of the papers.

Full experimental and/or methodical details must be provided.

Electronic files or software regarding the full details of the calculation and experimental procedure - if unable to be published in a normal way - can be deposited as supplementary material.

This journal covers all topics related to antibodies and antigens, topics of interest include (but are not limited to): antibody-producing cells (including B cells), antibody structure and function, antibody-antigen interactions, Fc receptors, antibody manufacturing antibody engineering, antibody therapy, immunoassays, antibody diagnosis, tissue antigens, exogenous antigens, endogenous antigens, autoantigens, monoclonal antibodies, natural antibodies, humoral immune responses, immunoregulatory molecules.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,800.00 CHF. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Monoclonal Antibodies in Cancer Therapy

  Citation: 583

  Authors: David, Louis

• Antibody Structure and Function: The Basis for Engineering Therapeutics

  Citation: 455

  Authors: Mark L., Dennis R., Alexey, Gary L.

• Design and Production of Bispecific Antibodies

  Citation: 201

  Authors: Qiong, Yiqun, Jaeyoung, Xiao, Yifeng, Tiexin, Kevin, Michael J.

• IgA: Structure, Function, and Developability

  Citation: 192

  Authors: Patrícia, Jenny M.

• Structure, Function, and Therapeutic Use of IgM Antibodies

  Citation: 186

  Authors: Bruce A., Ramesh, Angus M., Stephen F., Marvin S.

• David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments

  Citation: 179

  Authors: Adam, Christine A.

• Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment

  Citation: 171

  Authors: Rena, Robert, Emma, Stephen, Mark

• Autoantibodies in SLE: Specificities, Isotypes and Receptors

  Citation: 151

  Authors: Barbara, Nicolas

• Developments and Challenges for mAb-Based Therapeutics

  Citation: 136

  Authors: Sumit, Wei, Tsutomu, Satoshi

• Phage Display Libraries for Antibody Therapeutic Discovery and Development

  Citation: 129

  Authors: Juan C., Martha, Hugo Iván, Sonia Mayra